BIBR 1048 in the Prevention of Venous Thromboembolism in Patients Undergoing Primary Elective Total Hip Replacement Surgery
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
- To determine the therapeutic window of BIBR 1048 in order to select doses for further
studies in the development plan.
- Twice daily regimen will be tested for most dose levels and once daily administration
will also be evaluated when appropriate.